青光眼的药物治疗——2002年：如今每年的花费与年份相符吗？
Glaucoma medical treatment--2002: does yearly cost now equal the year?
作者信息
Doyle J William, Smith M Fran, Tierney John W
机构信息
Department of Ophthalmology, University of Florida College of Medicine, Gainesville, USA.
出版信息
Optom Vis Sci. 2002 Aug;79(8):489-92. doi: 10.1097/00006324-200208000-00010.
BACKGROUND
To review costs of the wide array of glaucoma medications available today as well as patient-assistance programs.
METHODS
Potential yearly costs for current frequently used single and multiple drug therapies were determined, taking into account the actual (not labeled) volume of drops in the bottled medications. Alternative modes for obtaining medications, such as compassionate-use programs, were also surveyed.
RESULTS
"Maximum" medical therapy may cost over $2000 per year. Allergan, Ciba, Merck, Pharmacia-Upjohn, and Alcon offer patient-assistance programs of variable simplicity of use.
DISCUSSION
The cost of maximum glaucoma medical therapy can assume a significant proportion of an elderly patient's yearly income.
背景
回顾当今可用的各种青光眼药物的成本以及患者援助项目。
方法
确定当前常用的单一和多种药物疗法的潜在年度成本，同时考虑瓶装药物中滴眼液的实际（而非标注）用量。还调查了获取药物的替代模式，如同情用药项目。
结果
“最大程度的”药物治疗每年可能花费超过2000美元。爱尔康、汽巴、默克、法玛西亚 - 普强和阿尔康都提供了使用简便程度各异的患者援助项目。
讨论
青光眼最大程度药物治疗的成本可能占老年患者年收入的很大一部分。
Zotero 插件